Skip to content

Research at St Andrews

Defining dormancy in mycobacterial disease

Research output: Research - peer-reviewArticle

DOI

Open Access permissions

Open

Author(s)

S. Lipworth, R.J.H. Hammond, V.O. Baron, Y. Hu, A. Coates, S.H. Gillespie

School/Research organisations

Abstract

Tuberculosis remains a threat to global health and recent attempts to shorten therapy have not succeeded mainly due to cases of clinical relapse. This has focussed attention on the importance of “dormancy” in tuberculosis. There are a number of different definitions of the term and a similar multiplicity of different in vitro and in vivo models. The danger with this is the implicit assumption of equivalence between the terms and models, which will make even more difficult to unravel this complex conundrum. In this review we summarise the main models and definitions and their impact on susceptibility of Mycobacterium tuberculosis. We also suggest a potential nomenclature for debate. Dormancy researchers agree that factors underpinning this phenomenon are complex and nuanced. If we are to make progress we must agree the terms to be used and be consistent in using them.
Close

Details

Original languageEnglish
Pages (from-to)131-142
Number of pages12
JournalTuberculosis
Volume99
Early online date28 May 2016
DOIs
StatePublished - Jul 2016

    Research areas

  • Mycobacterium tuberculosis, Dormancy, Latency, Persistence, Mycobacteria

Discover related content
Find related publications, people, projects and more using interactive charts.

View graph of relations

Related by author

  1. Pretreatment chest x-ray severity and its relation to bacterial burden in smear positive pulmonary tuberculosis

    Murthy, S. E., Chatterjee, F., Crook, A., Dawson, R., Mendel, C., Murphy, M. E., Murray, S. R., Nunn, A. J., Phillips, P. P. J., Singh, K. P., McHugh, T. D., Gillespie, S. H. & on behalf of the REMoxTB Consortium 21 May 2018 In : BMC Medicine. 16, 11 p., 73

    Research output: Research - peer-reviewArticle

  2. Greater early bactericidal activity at higher rifampicin doses revealed by modeling and clinical trial simulations

    Svensson, R. J., Svensson, E. M., Aarnoutse, R. E., Diacon, A. H., Dawson, R., Gillespie, S. H., Moodley, M., Boeree, M. J. & Simonsson, U. S. H. 28 Apr 2018 In : Journal of Infectious Diseases. In press

    Research output: Research - peer-reviewArticle

  3. Forecasting clinical dose-response from pre-clinical studies in tuberculosis research - translational predictions with rifampicin

    Wicha, S. G., Clewe, O., Svensson, R. J., Gillespie, S. H., Hu, Y., Coates, A. R. & Simonsson, U. S. 23 Apr 2018 (Accepted/In press) In : Clinical Pharmacology & Therapeutics. In press

    Research output: Research - peer-reviewArticle

Related by journal

  1. The impact of repeated NALC/NaOH- decontamination on the performance of Xpert MTB/RIF assay

    Rachow, A., Saathoff, E., Mtafya, B., Mapamba, D., Mangu, C., Rojas-Ponce, G., Ntinginya, N. E., Boeree, M., Heinrich, N., Gillespie, S. H., Hoelscher, M. & on behalf of the PanACEA-Consortium 4 Apr 2018 In : Tuberculosis. In press

    Research output: Research - peer-reviewArticle

  2. Serial image analysis of Mycobacterium tuberculosis colony growth reveals a persistent subpopulation in sputum during treatment of pulmonary TB

    Barr, D. A., Kamdolozi, M., Nishihara, Y., Ndhlovu, V., Khonga, M., Davies, G. R. & Sloan, D. J. May 2016 In : Tuberculosis. 98, p. 110-115 6 p.

    Research output: Research - peer-reviewArticle

  3. Kinetics of Mycobacterium tuberculosis-specific IFN-γ responses and sputum bacillary clearance in HIV-infected adults during treatment of pulmonary tuberculosis

    Mzinza, D. T., Sloan, D. J., Jambo, K. C., Shani, D., Kamdolozi, M., Wilkinson, K. A., Wilkinson, R. J., Davies, G. R., Heyderman, R. S. & Mwandumba, H. C. 1 Jul 2015 In : Tuberculosis. 95, 4, p. 463-469 7 p., 1343

    Research output: Research - peer-reviewArticle

  4. HspX knock-out in Mycobacterium tuberculosis leads to shorter antibiotic treatment and lower relapse rate in a mouse model - A potential novel therapeutic target

    Hu, Y., Liu, A., Menendez, M. C., Garcia, M. J., Oravcova, K., Gillespie, S. H., Davies, G. R., Mitchison, D. A. & Coates, A. R. M. Jan 2015 In : Tuberculosis. 95, 1, p. 31-36 6 p.

    Research output: Research - peer-reviewArticle

ID: 243086204